ASCOTODIN COLL FL 10ML

ASCOTODIN 3 MG/ML + 1 MG/ML COLLIRIUM, DEVELOPMENT

active ingredients

100 ml of solution contain. Active ingredients: N–methylbenzochinoline methylsulphate g 0.300, tonzilamine hydrochloride g 0.100. For the full list of excipients, see paragraph 6.1

Excellent

Sodium chloride, sodium borate, carbossimetilcellulose, p–oxybenzoic esters, purified water.

Therapeutic indications

Prevents professional and occasional photophalmic irritations and injuries. Therefore the use is indicated for all those (brasors, athletes, etc.) who are subjected to prolonged exposure to ultraviolet rays and very intense lights. It decreases the irritative phenomena from diffraction of light in the wearers of contact lenses. It is indicated as a curative in all the affections in which it dominates the photophobia symptom, atypical ophthalmies, electrical, keratin, iriti.

Contraindications

Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1. Children under the age of three. Subjects with narrow angle glaucoma and other severe eye diseases. Patients who are following an antidepressant drug therapy.

Population

Istill a drop twice, five minutes away, before exposure to too intense lights (ultra-violet rays, intense sun, strong artificial lights). Repeat after about three hours if the exposure continues. For contact lenses wearers a drop three times a day. In case of strong photophobia, the food can be made every two hours.

Conservation

Store at temperature not exceeding 30°C, sheltered from light.

Warnings

If symptoms persist or worsen after a short period of treatment, consult your doctor; in any case, the product should not be used for more than 7 consecutive days, given the possibility that undesirable effects may occur, even of a certain severity. Infections, pus, foreign bodies in the eye, mechanical, chemical damage, from heat require the attention of the doctor. The product, while presenting a poor systemic absorption, should be used with caution in patients suffering from hypertension, hyperthyroidism, heart disorders and hyperglycemia (diabetes) and in patients undergoing treatment with antidepressant drugs. The medicinal product, if accidentally ingested or used for a long period of excessive doses, may cause toxic phenomena. The medicinal product must be kept away from the sight and scope of children since accidental ingestion can cause deep sedation. This medicine contains para-oxybenzoic esters that can cause allergic reactions (also delayed). Pediatric population Collirium should not be used in children under the age of three.

Interactions

No special interactions or incompatibility with other medicines for ophthalmic use are known. Do not use ASCOTODIN simultaneously with antidepressant drug therapy (see paragraph 4.3).

Effects

The use of the medicine can sometimes determine pupilal dilation, systemic effects from absorption (hypertension, heart disorders, hyperglycemia), increased blood pressure, nausea, headache. Rarely, awareness-raising phenomena can occur. In this case it is necessary to stop the treatment and consult the doctor so that, where necessary, suitable therapy can be established. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose cases have been reported.

No contraindications are known.

Source: Farmadati